Ribas VT - Search Results

1

Editorial: Promoting nervous system regeneration by treatments targeting neuron-glia interactions.

De Lima S, Mietto BS, Ribas VT, Ribeiro-Resende VT, Oliveira ALR, Park KK. De Lima S, et al. Among authors: ribas vt. Front Cell Neurosci. 2024 Jan 11;17:1355469. doi: 10.3389/fncel.2023.1355469. eCollection 2023. Front Cell Neurosci. 2024. PMID: 38273976 Free PMC article. No abstract available.

2

Gene Manipulation Strategies to Identify Molecular Regulators of Axon Regeneration in the Central Nervous System.

Ribas VT, Costa MR. Ribas VT, et al. Front Cell Neurosci. 2017 Aug 7;11:231. doi: 10.3389/fncel.2017.00231. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28824380 Free PMC article. Review.

3

AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo.

Ribas VT, Vahsen BF, Tatenhorst L, Estrada V, Dambeck V, Almeida RA, Bähr M, Michel U, Koch JC, Müller HW, Lingor P. Ribas VT, et al. Cell Death Dis. 2021 Feb 26;12(2):213. doi: 10.1038/s41419-021-03503-3. Cell Death Dis. 2021. PMID: 33637688 Free PMC article.

4

Early c-Jun N-terminal kinase-dependent phosphorylation of activating transcription factor-2 is associated with degeneration of retinal ganglion cells.

Ribas VT, Arruda-Carvalho M, Linden R, Chiarini LB. Ribas VT, et al. Neuroscience. 2011 Apr 28;180:64-74. doi: 10.1016/j.neuroscience.2011.01.059. Epub 2011 Feb 18. Neuroscience. 2011. PMID: 21300140

5

Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration.

Lani-Louzada R, Marra C, Dias MS, de Araújo VG, Abreu CA, Ribas VT, Adesse D, Allodi S, Chiodo V, Hauswirth W, Petrs-Silva H, Linden R. Lani-Louzada R, et al. Among authors: ribas vt. Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):5. doi: 10.1167/iovs.63.2.5. Invest Ophthalmol Vis Sci. 2022. PMID: 35103748 Free PMC article.

6

Gene Therapy Strategies for Glaucomatous Neurodegeneration.

Lani-Louzada R, Dias MS, Linden R, Ribas VT, Petrs-Silva H. Lani-Louzada R, et al. Among authors: ribas vt. Curr Gene Ther. 2021;21(5):362-381. doi: 10.2174/1566523221666210126152000. Curr Gene Ther. 2021. PMID: 33573569 Review.

7

The Role of Axonal Transport in Glaucoma.

Dias MS, Luo X, Ribas VT, Petrs-Silva H, Koch JC. Dias MS, et al. Among authors: ribas vt. Int J Mol Sci. 2022 Apr 1;23(7):3935. doi: 10.3390/ijms23073935. Int J Mol Sci. 2022. PMID: 35409291 Free PMC article. Review.

8

Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues.

Vasconcelos CFM, Ribas VT, Petrs-Silva H. Vasconcelos CFM, et al. Among authors: ribas vt. Cells. 2023 Aug 28;12(17):2155. doi: 10.3390/cells12172155. Cells. 2023. PMID: 37681887 Free PMC article. Review.

9

AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease.

Balke D, Tatenhorst L, Dambeck V, Ribas VT, Vahsen BF, Michel U, Bähr M, Lingor P. Balke D, et al. Among authors: ribas vt. Mol Neurobiol. 2020 Feb;57(2):685-697. doi: 10.1007/s12035-019-01744-0. Epub 2019 Aug 24. Mol Neurobiol. 2020. PMID: 31446549

10

Does the use of recombinant AAV5 in pulmonary gene therapy lead to lung damage?

Martini SV, Fagundes SS, Schmidt AC, Avila M, Ornellas DS, Ribas VT, Petrs-Silva H, Linden R, Faffe DS, Guggino SE, Rocco PR, Zin WA, Morales MM. Martini SV, et al. Among authors: ribas vt. Respir Physiol Neurobiol. 2009 Sep 30;168(3):203-9. doi: 10.1016/j.resp.2009.06.016. Epub 2009 Jun 30. Respir Physiol Neurobiol. 2009. PMID: 19573627 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page